Page 18 - 2d News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from 2d. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn't seem to increase pancreatic cancer risk in a large population-based cohort study. ....
While tirzepatide has bagged FDA approval for treating T2D and for weight loss, the critical question remains can it also safeguard the kidneys, a key objective in diabetes care? ....
Multinational joint consensus statement summarized current evidence on diabetes stigma and discrimination and made recommendations for stakeholders including healthcare providers. ....